Les interactions entre le microbiome intestinal et les métabolites contribuent au risque de cancer de l'œsophage : données issues de la randomisation mendélienne et de l'intégration multiomique

Yang H, Liu Y, Zhu T, Xiao Z, Wang H, Zhu S, Chen Y. Gut Microbiome-Metabolite Interactions Contribute to Esophageal Cancer Risk: Evidence From Mendelian Randomization and Multiomics Integration. Int J Genomics. 2026 Jun 8;2026:5967802. doi: 10.1155/ijog/5967802. PMID: 42266611; PMCID: PMC13243870.

Metabolomic insights into associations between adiposity markers and liver cancer risk: Results from a prospective cohort study and Mendelian randomization analysis

Li ZY, Li HL, Wang J, Shen QM, Zou YX, Yang DN, Tan YT, Xiang YB. Metabolomic insights into associations between adiposity markers and liver cancer risk: Results from a prospective cohort study and Mendelian randomization analysis. PLoS Med. 2026 Feb 2;23(2):e1004910. doi: 10.1371/journal.pmed.1004910. PMID: 41628182; PMCID: PMC12863527.

Genetic determinants of head and neck cancer: exploring causality among immune cells and plasma metabolites through two-sample Mendelian randomization and mediation analysis

Lu Y, Du X, Liu H, He Q, Cao X. Genetic determinants of head and neck cancer: exploring causality among immune cells and plasma metabolites through two-sample Mendelian randomization and mediation analysis. Discov Oncol. 2025 Jul 12;16(1):1323. doi: 10.1007/s12672-025-03181-z. PMID: 40652067; PMCID: PMC12255607.